Alex Tonks

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Venues

Leukemia

International journal of nanomedicine

Antioxidants (Basel, Switzerland)

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Siân Rizzo, Mathieu Varache, Edward John Sayers, Arwyn T Jones, Alex Tonks, David W Thomas, Elaine L Ferguson
Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia. International journal of nanomedicine 19 (2024)
Siân Rizzo, Mathieu Varache, Edward John Sayers, Arwyn T Jones, Alex Tonks, David W Thomas, Elaine L Ferguson
Modification of the Antibiotic, Colistin, with Dextrin Causes Enhanced Cytotoxicity and Triggers Apoptosis in Myeloid Leukemia. International journal of nanomedicine 19 (2024)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia (2022)
Ana Catarina Menezes, Rachel Jones, Alina Shrestha, Rachael Nicholson, Adam Leckenby, Aleksandra Azevedo, Sara Davies, Sarah Baker, Amanda F Gilkes, Richard L Darley, Alex Tonks
Increased expression of RUNX3 inhibits normal human myeloid development. Leukemia 36 (7) (2022)
James Hillier, Gemma J Allcott, Laura A Guest, Wayne Heaselgrave, Alex Tonks, Myra E Conway, Amy L Cherry, Steven John Coles
The BCAT1 CXXC Motif Provides Protection against ROS in Acute Myeloid Leukaemia Cells. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia (2022)
Namrata Rastogi, Juan Bautista Menendez Gonzalez, Vikas Kumar Srivastava, Bader Alanazi, Rehab N Alanazi, Owen M Hughes, Niamh S O'Neill, Amanda F Gilkes, Neil Ashley, Sumukh Deshpande, Robert M Andrews, Adam J Mead, Neil P Rodrigues, Stephen Knapper, Richard L Darley, Alex Tonks
Nuclear factor I-C overexpression promotes monocytic development and cell survival in acute myeloid leukemia. Leukemia 37 (2) (2022)
Namrata Rastogi, Sarah Baker, Stephen T Man, Robert A Uger, Mark Wong, Steven J Coles, Marie Hodges, Amanda F Gilkes, Steven Knapper, Richard L Darley, Alex Tonks
Use of an anti-CD200-blocking antibody improves immune responses to AML in vitro and in vivo. British journal of haematology 193 (1) (2020)
Bader Alanazi, Chinmay R Munje, Namrata Rastogi, Andrew J K Williamson, Samuel Taylor, Paul S Hole, Marie Hodges, Michelle Doyle, Sarah Baker, Amanda F Gilkes, Steven Knapper, Andrew Pierce, Anthony D Whetton, Richard L Darley, Alex Tonks
Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia. Leukemia 34 (2) (2019)

Alex Tonks.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alex Tonks